Shu Jia

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.

Eugenie Kleinerman, Shu Jia, Jessica Griffin et al. · Journal of Clinical Oncology · 1992 · 156 citations

E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.

Zhichao Zhou, Shu Jia, Mien‐Chie Hung et al. · PubMed · 2001 · 65 citations

Cisplatin Sensitivity, Cell Death, Ii-targeting Anticancer Drugs +20

Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.

Elizabeth A. Lafleur, Shu Jia, Laura L. Worth et al. · PubMed · 2001 · 62 citations

Breast Oncology, Apoptosis, Immunology +18

Huc-MSCs-derived exosomes attenuate neuropathic pain by inhibiting activation of the TLR2/MyD88/NF-κB signaling pathway in the spinal microglia by targeting Rsad2

Xu Gao, Longfei Gao, Yanan Zhang et al. · International Immunopharmacology · 2022 · 62 citations · Full text

Mesenchymal stem cell-derived extracellular vesicles carrying miR-99b-3p restrain microglial activation and neuropathic pain by stimulating autophagy

Xu Gao, Longfei Gao, Xiangqing Kong et al. · International Immunopharmacology · 2023 · 45 citations

Regenerative Medicine, Neuroinflammation, Inflammation +13